AbCellera Biologics

(NASDAQ) ABCL

Current Price$4.09

Market Cap$1.25B

Since IPO (2020)-93%

5 Year-87%

1 Year+102%

1 Month+6%

AbCellera Biologics Financials at a Glance

Market Cap

$1.25B

Revenue (TTM)

$79.21M

Net Income (TTM)

$143.96M

EPS (TTM)

$-0.48

P/E Ratio

-8.53

Dividend

$0.00

Beta (Volatility)

1.37 (Average)

Dividend

$0.00

Beta (Volatility)

1.37 (Average)

Price

$4.09

Volume

348,343

Open

$4.24

Price

$4.09

Volume

348,343

Open

$4.24

Previous Close

$4.09

Daily Range

$4.00 - $4.28

52-Week Range

$1.94 - $6.51

Dividend

$0.00

Beta (Volatility)

1.37 (Average)

Price

$4.09

Volume

348,343

Open

$4.24

Previous Close

$4.09

Daily Range

$4.00 - $4.28

52-Week Range

$1.94 - $6.51

ABCL News

Financial Technologies - binary code background with dollar banknotes

How to Invest Like Peter Thiel

Jon QuastMay 1, 2026

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

Cory RenauerJul 21, 2024

investor-looks-worried-at-computer-in-a-living-room-setting-getty

Page 1

ABCL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AbCellera Biologics

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

562

CEO

Carl Lars G. Hansen, PhD

Website

www.abcellera.com

Headquarters

Vancouver, BC V5Y 0A1, CA

ABCL Financials

Key Financial Metrics (TTM)

Gross Margin

79%

Operating Margin

-3%

Net Income Margin

-2%

Return on Equity

-15%

Return on Capital

-17%

Return on Assets

-11%

Earnings Yield

-11.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.25B

Shares Outstanding

305.38M

Volume

348.34K

Avg. Volume

5.09M

Financials (TTM)

Gross Profit

$46.31M

Operating Income

$217.10M

EBITDA

$188.28M

Operating Cash Flow

$131.29M

Capital Expenditure

$42.77M

Free Cash Flow

$174.07M

Cash & ST Invst.

$560.33M

Total Debt

$143.22M

AbCellera Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$8.31M

+96.3%

Gross Profit

$340.00K

-108.0%

Gross Margin

-4.09%

N/A

Market Cap

$1.25B

N/A

Market Cap/Employee

$2.10M

N/A

Employees

596

N/A

Net Income

$43.16M

+5.4%

EBITDA

$48.86M

+5.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$364.55M

-32.2%

Accounts Receivable

$115.72M

-8.6%

Inventory

$0.00

N/A

Long Term Debt

$134.31M

+112.5%

Short Term Debt

$5.87M

+26.6%

Return on Assets

-11.01%

N/A

Return on Invested Capital

-16.82%

N/A

Free Cash Flow

$37.35M

-68.3%

Operating Cash Flow

$33.52M

-190.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XERSXeris Biopharma Holdings, Inc.

XERSXeris Biopharma Holdings, Inc.$6.24-2.19%

NUVBNuvation Bio Inc.

NUVBNuvation Bio Inc.$4.32-8.47%

BHVNBiohaven Ltd.

BHVNBiohaven Ltd.$8.76-2.88%

JANXJanux Therapeutics, Inc.

JANXJanux Therapeutics, Inc.$13.89-3.47%

SIONSionna Therapeutics, Inc.

SIONSionna Therapeutics, Inc.$40.22-5.96%

PHVSPharvaris N.V.

PHVSPharvaris N.V.$30.40-0.98%

IMNMImmunome, Inc.

IMNMImmunome, Inc.$20.88-5.18%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

PIIIP3 Health Partners

PIIIP3 Health Partners$11.29+1.80%

Questions About ABCL

What is the current price of AbCellera Biologics?

AbCellera Biologics is trading at $4.10 per share.

What is the 52-week range for AbCellera Biologics?

Over the past 52 weeks, AbCellera Biologics has traded between $1.94 and $6.52.

How much debt does AbCellera Biologics have?

As of the most recent reporting period, AbCellera Biologics reported total debt of $140.18M.

How much cash does AbCellera Biologics have on hand?

AbCellera Biologics reported $102.06M in cash and cash equivalents in its most recent financial results.

What is AbCellera Biologics’s dividend yield?

AbCellera Biologics does not currently have a dividend yield.

AbCellera Biologics

AbCellera Biologics Financials at a Glance

ABCL News

How to Invest Like Peter Thiel

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

Down 57%, Is AbCellera Biologics a Buy on the Dip?

3 Growth Stocks That Could Go Parabolic in 2024

1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy

Why AbCellera Biologics Rallied as Much as 24% on Wednesday

Why AbCellera Biologics Is 10% Lower Today

Why AbCellera Biologics Stock Sank 21.6% in October

ABCL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About AbCellera Biologics

ABCL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

AbCellera Biologics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ABCL

What is the current price of AbCellera Biologics?

What is the 52-week range for AbCellera Biologics?

How much debt does AbCellera Biologics have?

How much cash does AbCellera Biologics have on hand?

What is AbCellera Biologics’s dividend yield?

Premium Investing Services